医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

EFIL Center Is Attracting Overseas Patients to Its Exophthalmos Center, Korea

2017年03月02日 PM06:03
このエントリーをはてなブックマークに追加


 

DAEGU, South Korea

JCI(Joint Commission International)-accredited EFIL Plastic Surgery is drawing attention across the globe with its exophthalmos surgery.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170302005521/en/

Before and after the ocular proptosis surgery of EFIL Plastic Surgery (Graphic: Business Wire)

Before and after the ocular proptosis surgery of EFIL Plastic Surgery (Graphic: Business Wire)

As medical institutions that treat exophthalmos are getting globally very unique, patients across the world are visiting EFIL Exophthalmos Center to protect eyeballs and treat bulging eyes.

In EFIL Center, patients can receive treatment for proptosis caused by aesthetic issues or hormonal issues like hyperthyroidism. If the eyes are protruded since birth or during childhood, surgery for aesthetic purpose is available to adults over 18 years old. However, surgery for proptosis caused by hyperthyroidism is only available after hyperthyroidism is fully recovered or treated for more than one year.

“Eye socket expansion surgery” involves conjunctival incisions inside the corner of the eye for invisible scars. This procedure exposes and expands the orbital bone and pushes them to create a bigger space to allow bulging eyes to sit further back in the head. This procedure will take about an hour and allows one day discharge generally. Many overseas patients who can stay for one or two weeks may receive this treatment considering the recovery period. Patient satisfaction is high as the procedure actually sets the eyeballs back, which is not an optical illusion as real effect of eyeball setback.

EFIL Center achieved JCI accreditation which is globally accredited for patient safety and facility. JCI is designated by World Health Organization (WHO), which is only given to healthcare institutions if they meet or exceed strict international standards. JCI-accredited EFIL center has a high reputation of “a world-class safe healthcare clinic.”

Especially, not only patients from overseas trust JCI accreditation but increasingly more patients from Korea visit EFIL Exophthalmos Center.

Dr. Peter Kim, who is the chief of EFIL center, says, “We achieved high rankings and reputation with JCI accreditation for international standards in patient safety and facility. Therefore we can serve customers who want surgical services with patients safety and standard with global healthcare. The most skilled experienced surgeons will try best for your successful results for protruded eyes.”

View source version on businesswire.com: http://www.businesswire.com/news/home/20170302005521/en/

CONTACT

EFIL Exophthalmos Center & Plastic Surgery Center, KOREA
Peter
Chan Woo, Kim, +82-10-4616-9973
M.D., PhD., MBA.
psman007@gmail.com
http://efil-face.com/index.htm

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Konica Minolta and Innovation Network Corporation of Japan Close Acquisition of Ambry Genetics
  • Median Technologies Appoints Vivian Wang as General Manager, China and Takashi Hayashi as Managing Director, Japan
  • Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs
  • 武田薬品がALK陽性非小細胞肺がんでのALUNBRIGTM(ブリガチニブ)のピボタル第2相ALTA試験の最新データを発表
  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″